Long-term follow-up results of hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia (ALL).

被引:0
|
作者
O'Brien, S [1 ]
Thomas, D [1 ]
Cortes, J [1 ]
Faderl, S [1 ]
Giles, F [1 ]
Pierce, S [1 ]
Shan, J [1 ]
Ferrajoli, A [1 ]
Keating, M [1 ]
Kantarjian, H [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6539
引用
收藏
页码:567S / 567S
页数:1
相关论文
共 50 条
  • [1] Update of the HYPER-CVAD dose-intensive regimen in adult acute lymphocytic leukemia (ALL).
    Kantarjian, H
    O'Brien, S
    Keating, MJ
    Cortes, J
    Giles, FJ
    Beran, M
    Koller, C
    Andreeff, M
    Kornblau, S
    Pierce, S
    Murphy, S
    Freireich, EJ
    BLOOD, 1998, 92 (10) : 313A - 313A
  • [2] Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia
    Kantarjian, H
    Thomas, D
    O'Brien, S
    Cortes, J
    Giles, F
    Jeha, S
    Bueso-Ramos, CE
    Pierce, S
    Shan, JQ
    Koller, C
    Beran, M
    Keating, M
    Freireich, EJ
    CANCER, 2004, 101 (12) : 2788 - 2801
  • [3] Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia
    Kantarjian, HM
    O'Brien, S
    Smith, TL
    Cortes, J
    Giles, FJ
    Beran, M
    Pierce, S
    Huh, Y
    Andreeff, M
    Koller, C
    Ha, CS
    Keating, MJ
    Murphy, S
    Freireich, EJ
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 547 - 561
  • [4] Long-term follow-up after frontline therapy with the Hyper-CVAD and imatinib mesylate regimen in adults with Philadelphia (Ph) positive acute lymphocytic leukemia (ALL)
    Thomas, Deborah A.
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Faderl, Stefan
    Garcia-Manero, Guillermo
    Wierda, William
    Ferrajoli, Alessandra
    Vertovsek, Srdan
    Jones, Dan
    Letvak, Laurie
    Champlin, Richard
    Cortes, Jorge
    O'Brien, Susan
    BLOOD, 2007, 110 (11) : 10A - 11A
  • [5] The hyper-CVAD regimen in adult acute lymphocytic leukema
    Garcia-Manero, G
    Kantarjian, HM
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2000, 14 (06) : 1381 - +
  • [6] Update of the modified hyper-CVAD regimen in newly diagnosed adult acute lymphocytic leukemia (ALL).
    Thomas, DA
    Cortes, J
    Giles, F
    O'Brien, S
    Faderl, S
    Garcia-Manero, G
    Beran, M
    Koller, C
    Andreeff, M
    Kornblau, S
    Keating, M
    Kantarjian, H
    BLOOD, 2003, 102 (11) : 880A - 880A
  • [7] MODIFIED BURKITT REGIMEN FOR ADULT ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) - THE HYPER-CVAD PROGRAM
    KANTARJIAN, H
    OBRIEN, S
    BERAN, M
    ESCUDIER, S
    PIERCE, S
    ESTEY, E
    KOLLER, C
    ROBERTSON, B
    ANDREEFF, M
    KEATING, M
    BOWMAN, P
    MURPHY, S
    FREIREICH, E
    BLOOD, 1993, 82 (10) : A329 - A329
  • [8] RESULTS OF TREATMENT WITH HYPER-CVAD MTX-ARA-C, A DOSE-INTENSIVE REGIMEN, IN ADULT ACUTE LYMPHOCYTIC LEUKEMIA AND HIGHLY AGGRESSIVE LYMPHOMA IN A SINGLE CENTER IN CHINA
    Niu, T.
    Liu, T.
    Xiang, B. X.
    Jia, Y-O.
    Zhu, H. -L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 4 - 4
  • [9] HYPER-CVAD IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: AN ANALYSIS OF THE DOSE-INTENSIVE (INDUCTION-CONSOLIDATION) PHASE
    Silva-Coelho, P.
    Carneiro, A.
    Carvalho, I.
    Principe, F.
    Guimaraes, J. E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 6 - 6
  • [10] Outcome with Hyper-CVAD/MTX-Ara-C, a dose-intensive regimen, in acute lymphocytic leukemia and highly aggressive lymphoma in China.
    Niu, Ting
    Liu, Ting
    Xiang, Bing
    Chang, Hong
    Jia, Yong-qian
    Zhu, Huan-ling
    BLOOD, 2007, 110 (11) : 150B - 150B